Form 4: Iron Mountain Director Sells 7,000 Shares

Iron Mountain Director Jennifer Allerton sold 7,000 shares of common stock for approximately $108.88 per share under a 10b5-1 plan.

Summary

• Jennifer Allerton, a Director of Iron Mountain Incorporated (IRM), sold 7,000 shares of the company's common stock.
• The transaction occurred on March 2, 2026, and was executed pursuant to a Rule 10b5-1(c) plan.
• The shares were sold at a weighted average price of $108.88 per share, with individual transaction prices ranging from $108.86 to $109.00.
• Following this transaction, Jennifer Allerton directly beneficially owns 11,541 shares of Iron Mountain common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative signal due to a director's sale of shares, although the impact is somewhat mitigated by the transaction being executed under a Rule 10b5-1 plan, suggesting a pre-determined sale rather than an immediate reaction to new information.

Negatives

• A director, Jennifer Allerton, sold 7,000 shares of company stock, reducing her direct beneficial ownership.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that insider sales, even when pre-planned under Rule 10b5-1, are often scrutinized by investors for potential signals regarding management's confidence in the company's future prospects. While not inherently negative, a sale by a director could be interpreted in various ways depending on the broader market and company-specific news.

Stakeholder Impact

• Shareholders may interpret the director's sale as a potential signal regarding the company's future performance or valuation, potentially influencing their investment decisions.

Key Dates

Recommendation

While an insider sale by a director can be a negative signal, the transaction was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled and not necessarily a reaction to new, adverse information. Given this context, and without further company-specific news, a 'hold' recommendation is appropriate as the sale itself doesn't provide a strong enough catalyst for a 'sell' or 'buy' decision.

Keywords

Iron Mountain, IRM, Insider Sale, Form 4, Jennifer Allerton, Director, Stock Transaction, Equity Sale, 10b5-1 Plan